Melissa Crabbé

510 total citations
14 papers, 179 citations indexed

About

Melissa Crabbé is a scholar working on Radiology, Nuclear Medicine and Imaging, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Melissa Crabbé has authored 14 papers receiving a total of 179 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Radiology, Nuclear Medicine and Imaging, 5 papers in Cellular and Molecular Neuroscience and 5 papers in Neurology. Recurrent topics in Melissa Crabbé's work include Radiopharmaceutical Chemistry and Applications (6 papers), Parkinson's Disease Mechanisms and Treatments (5 papers) and Medical Imaging Techniques and Applications (3 papers). Melissa Crabbé is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (6 papers), Parkinson's Disease Mechanisms and Treatments (5 papers) and Medical Imaging Techniques and Applications (3 papers). Melissa Crabbé collaborates with scholars based in Belgium, Spain and Portugal. Melissa Crabbé's co-authors include Cindy Casteels, Koen Van Laere, Anke Van der Perren, Veerle Baekelandt, Uwe Himmelreich, Guy Bormans, Akila Weerasekera, Ilse Bollaerts, Marijke De Saint‐Hubert and Lara Struelens and has published in prestigious journals such as Scientific Reports, Experimental Neurology and Neurobiology of Aging.

In The Last Decade

Melissa Crabbé

14 papers receiving 179 citations

Peers

Countries citing papers authored by Melissa Crabbé

Since Specialization

Citations

This map shows the geographic impact of Melissa Crabbé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa Crabbé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa Crabbé more than expected).

Fields of papers citing papers by Melissa Crabbé

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melissa Crabbé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa Crabbé. The network helps show where Melissa Crabbé may publish in the future.

Co-authorship network of co-authors of Melissa Crabbé

This figure shows the co-authorship network connecting the top 25 collaborators of Melissa Crabbé. A scholar is included among the top collaborators of Melissa Crabbé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melissa Crabbé. Melissa Crabbé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Targeted radiopharmaceuticals: an underexplored strategy for ovarian cancer 2024 ·Theranostics ·Melissa Crabbé, (unknown), Koen Vermeulen, Maarten Ooms, (unknown)	1
2	The Emission of Internal Conversion Electrons Rather Than Auger Electrons Increased the Nucleus-Absorbed Dose for¹⁶¹Tb Compared with¹⁷⁷Lu with a Higher Dose Response for [¹⁶¹Tb]Tb-DOTA-LM3 Than for [¹⁶¹Tb]Tb-DOTATATE 2024 ·Journal of Nuclear Medicine ·(unknown), Lara Struelens, Koen Vermeulen, Marijke De Saint‐Hubert, Michel Koole, Melissa Crabbé	3
3	Preclinical evaluation of CXCR4 peptides for targeted radionuclide therapy in glioblastoma 2024 ·EJNMMI Radiopharmacy and Chemistry ·(unknown), Melissa Crabbé, Virginie Neirinckx, (unknown), Jasmien Wellens, Bernard Rogister, Mohammed Abderrafi Benotmane, Koen Vermeulen	2
4	A Review on Tumor Control Probability (TCP) and Preclinical Dosimetry in Targeted Radionuclide Therapy (TRT) 2022 ·Pharmaceutics ·(unknown), Melissa Crabbé, Lara Struelens, Marijke De Saint‐Hubert, Michel Koole	7
5	Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [153Sm]Sm-DOTA-TATE 2022 ·Pharmaceutics ·Koen Vermeulen, Michiel Van de Voorde, (unknown), (unknown), (unknown), (unknown), Charlotte Duchemin, Melissa Crabbé, (unknown), (unknown), Reinhard Heinke, Laura Lambert, (unknown), Andrew R. Burgoyne, T. E. Cocolios, Thierry Storà, Maarten Ooms	3
6	Review of extremity dosimetry in nuclear medicine 2021 ·Journal of Radiological Protection ·(unknown), (unknown), Jérémie Dabin, Peter Covens, (unknown), Melissa Crabbé, (unknown), (unknown), M. Ginjaume, (unknown)	17
7	Targeted alpha therapy: a critical review of translational dosimetry research with emphasis on actinium-225 2020 ·The Quarterly Journal of Nuclear Medicine and Molecular Imaging ·(unknown), Marijke De Saint‐Hubert, Melissa Crabbé, Lara Struelens, Michel Koole	12
8	Non-invasive characterization of amyotrophic lateral sclerosis in a hTDP-43A315T mouse model: A PET-MR study 2020 ·NeuroImage Clinical ·Akila Weerasekera, Melissa Crabbé, Sandra O. Tomé, Willy Gsell, Diana M. Sima, Cindy Casteels, Tom Dresselaers, Christophe M. Deroose, Sabine Van Huffel, Dietmar Rudolf Thal, Philip Van Damme, Uwe Himmelreich	14
9	Excitotoxic neurodegeneration is associated with a focal decrease in metabotropic glutamate receptor type 5 availability: an in vivo PET imaging study 2019 ·Scientific Reports ·Melissa Crabbé, (unknown), Cindy Casteels, Koen Van Laere	15
10	Regional changes in the type 1 cannabinoid receptor are associated with cognitive dysfunction in Parkinson’s disease 2019 ·European Journal of Nuclear Medicine and Molecular Imaging ·Jenny Ceccarini, Cindy Casteels, Rawaha Ahmad, Melissa Crabbé, Laura Van de Vliet, (unknown), Mathieu Vandenbulcke, Wim Vandenberghe, Koen Van Laere	21
11	Increased P2X7 Receptor Binding Is Associated With Neuroinflammation in Acute but Not Chronic Rodent Models for Parkinson’s Disease 2019 ·Frontiers in Neuroscience ·Melissa Crabbé, Anke Van der Perren, Ilse Bollaerts, (unknown), Veerle Baekelandt, Guy Bormans, Cindy Casteels, Lieve Moons, Koen Van Laere	39
12	Temporal changes in neuroinflammation and brain glucose metabolism in a rat model of viral vector-induced α-synucleinopathy 2019 ·Experimental Neurology ·Melissa Crabbé, Anke Van der Perren, (unknown), (unknown), Guy Bormans, Veerle Baekelandt, Cindy Casteels, Koen Van Laere	13
13	Neuromelanin-MRI in REM sleep behaviour disorder predicts dopaminergic dysfunction and clinical risk of Parkinson's disease 2018 ·Movement Disorders ·Thomas R. Barber, Ludovica Griffanti, Karen N. Bradley, (unknown), Melissa Crabbé, Christine Lo, (unknown), (unknown), Meiqin Hu	1
14	Altered mGluR5 binding potential and glutamine concentration in the 6-OHDA rat model of acute Parkinson's disease and levodopa-induced dyskinesia 2017 ·Neurobiology of Aging ·Melissa Crabbé, Anke Van der Perren, Akila Weerasekera, Uwe Himmelreich, Veerle Baekelandt, Koen Van Laere, Cindy Casteels	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact